[go: up one dir, main page]

ES2097490T3 - Composiciones farmaceuticas a base de ebastina o de sus analogos. - Google Patents

Composiciones farmaceuticas a base de ebastina o de sus analogos.

Info

Publication number
ES2097490T3
ES2097490T3 ES93901804T ES93901804T ES2097490T3 ES 2097490 T3 ES2097490 T3 ES 2097490T3 ES 93901804 T ES93901804 T ES 93901804T ES 93901804 T ES93901804 T ES 93901804T ES 2097490 T3 ES2097490 T3 ES 2097490T3
Authority
ES
Spain
Prior art keywords
pct
ebastine
analogs
pharmaceutical compositions
compositions based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93901804T
Other languages
English (en)
Inventor
Jean-Marc Bobee
Guillaume Conrath
Gabriel Gousset
Michel Ponsot
Michel Veillard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9419600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2097490(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Application granted granted Critical
Publication of ES2097490T3 publication Critical patent/ES2097490T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVAS COMPOSICIONES SOLIDAS A BASE DE DERIVADOS DE LA PIPERIDINA SUSTITUIDA EN 1,4 PRESENTE BAJO UNA FORMA MICRONIZADA E HIDROFILIZADA.
ES93901804T 1991-12-03 1992-12-01 Composiciones farmaceuticas a base de ebastina o de sus analogos. Expired - Lifetime ES2097490T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9114936A FR2684298B1 (fr) 1991-12-03 1991-12-03 Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.

Publications (1)

Publication Number Publication Date
ES2097490T3 true ES2097490T3 (es) 1997-04-01

Family

ID=9419600

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93901804T Expired - Lifetime ES2097490T3 (es) 1991-12-03 1992-12-01 Composiciones farmaceuticas a base de ebastina o de sus analogos.

Country Status (12)

Country Link
US (1) US5460829A (es)
EP (1) EP0614362B1 (es)
JP (1) JP3518601B2 (es)
AT (1) ATE148990T1 (es)
CA (1) CA2123232C (es)
DE (1) DE69217554T2 (es)
DK (1) DK0614362T5 (es)
ES (1) ES2097490T3 (es)
FR (1) FR2684298B1 (es)
GR (1) GR3022615T3 (es)
HK (1) HK1006273A1 (es)
WO (1) WO1993010782A1 (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2231043A1 (es) * 2004-10-29 2005-05-01 Laboratorios Cinfa, S.A. Composicion farmaceutica de ebastina de liberacion inmediata y su proceso de fabricacion.
US11617751B2 (en) 2006-07-06 2023-04-04 Bayer Pharma AG Pharmaceutical composition containing a tetrahydrofolic acid

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5717025A (en) * 1996-09-16 1998-02-10 H. B. Fuller Licensing & Financing, Inc. Melamine-formaldehyde resin based adhesive compositions
JP2007246539A (ja) * 1997-10-20 2007-09-27 Dainippon Sumitomo Pharma Co Ltd 速溶性医薬組成物
US6737550B2 (en) 2001-06-13 2004-05-18 Biogal Gryogyszergyar Rt. Process for preparing rac-bicalutamide and its intermediates
AU2003221355A1 (en) * 2002-03-12 2003-09-22 Y's Therapeutics Co., Limited Compounds capable of inhibiting immunocyte-related allergic immune reactions
AU2003242236A1 (en) * 2002-06-10 2003-12-22 Dainippon Pharmaceutical Co., Ltd. Rapidly disintegrating tablet and process for producing the same
US20050008691A1 (en) * 2003-05-14 2005-01-13 Arturo Siles Ortega Bicalutamide compositions
EP1716848B1 (en) * 2005-04-25 2007-04-25 Laboratorios Alter, S.A. Solid pharmaceutical composition containing a crystalline derivative of piperidine substituted in the 1,4 position
JP2008543766A (ja) * 2005-06-09 2008-12-04 エラン ファーマ インターナショナル リミテッド ナノ粒子エバスチン製剤
ES2277767B1 (es) * 2005-11-04 2008-04-01 Simbec Iberica, S.L. Formas orales solidas de ebastina.
JP2007297348A (ja) * 2006-05-02 2007-11-15 Daito Kk エバスチンを含有する錠剤
DE102008000351B4 (de) 2008-02-20 2017-08-10 Aristo Pharma Gmbh Verfahren zur Herstellung eines Ebastin enthaltenden Granulats sowie einer festen pharmazeutischen Zusammensetzung, Ebastin enthaltendes Granulat und dessen Verwendung
DE202011000756U1 (de) 2011-03-31 2011-10-12 Micro Labs Limited Ebastine, nicht-mikronisierte Ebastinepartikel und pharmazeutische Zusammensetzungen umfassend Ebastine
WO2013062498A1 (en) * 2011-10-13 2013-05-02 Mahmut Bilgic Solid oral formulations comprising ebastine
WO2013081562A1 (en) 2011-10-13 2013-06-06 Mahmut Bilgic Oral formulations comprising ebastine
ES2606148T3 (es) 2011-11-01 2017-03-22 Inopharm Limited Composición de disgregación oral de agentes antihistamínicos
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CN105326802A (zh) * 2015-09-01 2016-02-17 杭州澳医保灵药业有限公司 一种依巴斯汀分散片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8321157D0 (en) * 1983-08-05 1983-09-07 Fordonal Sa Piperidine derivatives
US4871733A (en) * 1984-04-09 1989-10-03 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4829064A (en) * 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4975426A (en) * 1987-06-08 1990-12-04 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
DE3720493A1 (de) * 1987-06-20 1989-01-26 Nattermann A & Cie Arzneizubereitungen mit mikronisierten ebselen-kristallen
ES2044100T4 (es) * 1988-04-27 1996-07-16 Schering Corp Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
JP2642486B2 (ja) * 1989-08-04 1997-08-20 田辺製薬株式会社 難溶性薬物の超微粒子化法
US5356887A (en) * 1990-01-31 1994-10-18 Merck & Co., Inc. Pharmaceutical compositions containing insoluble calcium salts of amino-hydroxybutylidene bisphoshonic acids
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2231043A1 (es) * 2004-10-29 2005-05-01 Laboratorios Cinfa, S.A. Composicion farmaceutica de ebastina de liberacion inmediata y su proceso de fabricacion.
US11617751B2 (en) 2006-07-06 2023-04-04 Bayer Pharma AG Pharmaceutical composition containing a tetrahydrofolic acid

Also Published As

Publication number Publication date
EP0614362B1 (fr) 1997-02-19
DK0614362T3 (da) 1997-03-10
JPH07501533A (ja) 1995-02-16
FR2684298B1 (fr) 1994-03-11
HK1006273A1 (en) 1999-02-19
FR2684298A1 (fr) 1993-06-04
US5460829A (en) 1995-10-24
ATE148990T1 (de) 1997-03-15
GR3022615T3 (en) 1997-05-31
EP0614362A1 (fr) 1994-09-14
CA2123232A1 (fr) 1993-06-10
DE69217554T2 (de) 1997-08-07
CA2123232C (fr) 2005-02-15
WO1993010782A1 (fr) 1993-06-10
DE69217554D1 (de) 1997-03-27
DK0614362T5 (da) 2008-11-10
JP3518601B2 (ja) 2004-04-12

Similar Documents

Publication Publication Date Title
ES2097490T3 (es) Composiciones farmaceuticas a base de ebastina o de sus analogos.
MY117274A (en) Polycyclic amine compounds and their enantiomers,their method of preparation and pharmaceutical compositions in which they are present.
UA39168C2 (uk) Фторалкоксифенільні похідні піперидину або хінуклідину, що є антагоністами речовини p і фармацевтична композиція на їх основі
DK0414263T3 (da) Fremgangsmåde til stabilisering af et fast farmaceutisk præparat indeholdende cycliske aminosyrer
PL315636A1 (en) Cosmetic or pharmaceutic compositions containing magnipherine or its derivatives
FR2662162B1 (fr) Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
AU6690686A (en) Piperdine derivative and pharmaceutical composition
NZ225344A (en) 3-demethylmevalonic acid derivatives and lactones and pharmaceutical compositions; intermediates for the preparation thereof
DK0513543T3 (da) Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og antikoagulationsmidler med indehold deraf
FR2694004B1 (fr) Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
ATE16488T1 (de) M-4- und isom-4-derivate, ihre herstellung und diese enthaltende zusammensetzungen.
DK0623121T3 (da) Fremstilling af N-acetylneuraminsyrederivater
MY101566A (en) Pharmaceutical compositions.
DK0450420T3 (da) Heterocyclisk substituerede dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
NO912888D0 (no) Fremgangsmaate for fremstilling av nye peperidylethere og -thioethere.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
DK0623138T3 (da) Nye adenosinderivater, fremgangsmåder til deres fremstilling og farmaceutiske præparater med indhold deraf
DK0625153T3 (da) Nyt isoindolinonderivat, dets fremstilling og farmaceutiske præparater med et indhold deraf
MY159418A (en) New derivatives of flavones, their preparation process, their use as medicaments, pharmaceutical compositions and new use
IT1274483B (it) Composizioni farmaceutiche contenenti gemfibrozil
ES2062214T3 (es) Derivados de aminooligohidroxi inhibidores de renina.
DK0418990T3 (da) 13-brom- og 13,14-dibrom-ergoliner, deres fremstilling og anvendelse i lægemidler
IL99369A0 (en) Pharmaceutical compositions containing substituted 2-cyclohexene derivatives
AU1466592A (en) Gem-diphosphonic acid nitrosocarbamoyl derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
IL102648A (en) Pharmaceutical compositions for controlling neuropathies caused by diabetes mellitus comprising calcium antagonists from the 1,4-dihydropyridine family

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 614362

Country of ref document: ES